FeliCure™ Therapeutic Antibody Discovery Platform

Creative Biolabs is at the forefront of a new era in veterinary medicine, committed to advancing feline health through the power of monoclonal antibody (mAb) therapies. Cats have unique physiological and immunological needs that demand specialized solutions. Our FeliCure™ Therapeutic Antibody Discovery Platform is engineered exclusively for this purpose, providing our partners in biotechnology and animal health with a powerful, end-to-end solution to develop next-generation feline biologics. FeliCure™ is your strategic advantage in tackling the most challenging feline diseases, from chronic inflammation and infectious agents to oncology.

Key Features of FeliCure™ Platform

Our platform integrates sophisticated molecular biology with a highly refined discovery workflow, ensuring the development of safe and effective therapeutic candidates.

  • Unparalleled Library Diversity
    We begin with a vast and robust feline-specific antibody library, maximizing the potential to identify high-affinity and novel candidates against even the most difficult targets.
  • Accelerated Discovery Engine
    Our streamlined screening and validation processes rapidly move projects from initial hit identification to fully characterized lead candidates, significantly reducing development timelines.
  • Feline-Optimized for Safety & Efficacy
    Every antibody discovered on our platform is engineered for optimal compatibility with the feline immune system, minimizing the risk of immunogenicity and maximizing therapeutic potential.
  • Broad Therapeutic Applicability
    FeliCure™ is a versatile platform adaptable to a wide range of indications, including immunology, oncology, infectious diseases, and metabolic disorders.
(Creative Biolabs Authorized)

Request a Consultation

Service Workflow

Workflow Description
Collaborative Target Assessment We partner with you to align on project goals, define critical-path assays, and design a bespoke discovery strategy tailored to your specific target.
Hit Generation & Screening Leveraging the full power of the FeliCure™ platform, we isolate a diverse panel of promising antibody hits with the desired binding characteristics.
Rigorous Candidate Profiling Hits undergo comprehensive, high-throughput characterization for affinity, specificity, and biological function to pinpoint the most promising lead candidates for development.
Advanced Lead Engineering We apply advanced protein engineering techniques to optimize your lead candidates for potency, stability, and manufacturability, ensuring they meet your precise therapeutic product profile.
Preclinical Candidate Package We deliver a comprehensive data package with fully characterized, production-ready mAb candidates, empowering your rapid transition into preclinical and clinical development.

R&D Capabilities

Our dedicated team possesses deep, cross-functional expertise in feline immunology, antibody engineering, and veterinary therapeutic development. Our state-of-the-art labs and integrated R&D capabilities ensure every project is executed with scientific rigor and a clear focus on clinical translation.

  • Specialized Feline Biology: In-depth knowledge of feline-specific disease pathways and immune responses.
  • Sophisticated Antibody Engineering: Expertise in affinity maturation, stability enhancement, and felinization.
  • Comprehensive Assay Development: A full suite of binding, cellular, and functional assays to validate candidate performance.
  • Multidisciplinary Approach: Seamless integration of molecular biology, bioanalytics, and veterinary science to overcome complex challenges.

Why Canine Therapeutic Antibodies?

Monoclonal antibodies are setting a new standard of care in human health, and they hold the same transformative promise for our feline companions. As the demand for advanced, targeted therapies grows, FeliCure™ empowers you to lead this evolution.

  • Addressing Unmet Needs: Cats suffer from a range of complex conditions like chronic kidney disease, viral infections, and cancer that are poorly addressed by conventional small molecules. Biologics offer a new path forward.
  • Species-Specific by Design: Therapies designed specifically for the feline immune system offer superior safety and efficacy compared to repurposed or cross-reactive antibodies, which can cause adverse immune reactions.
  • Significant Market Opportunity: The feline health market is expanding rapidly. Developing innovative, first-in-class mAb therapies provides a significant competitive advantage and opens new commercial avenues.
(Creative Biolabs Authorized)

Partner with Creative Biolabs

With the FeliCure™ Therapeutic Antibody Discovery Platform, Creative Biolabs offers you a reliable partner to pioneer the future of feline therapeutics. Whether you need a full discovery program or tailored support at specific stages, we are here to accelerate your innovation.

Contact us today to discuss your project and explore how FeliCure™ can drive your antibody discovery success.

Contact Our Team

Technology Platforms

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.